4 edition of Prognosis and risk assessment in cardiovascular disease found in the catalog.
Includes bibliographical references and index.
|Statement||edited by Amar S. Kapoor, Bramah N. Singh.|
|Contributions||Kapoor, Amar S., Singh, B. N.|
|LC Classifications||RC669 .P74 1993|
|The Physical Object|
|Pagination||xviii, 578 p. :|
|Number of Pages||578|
|LC Control Number||92049268|
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. ;– PubMed CrossRef PubMedCentral Google Scholar The Guidelines for the Management of Absolute Cardiovascular Disease Risk make recommendations regarding the management of cardiovascular risk in Australian adults aged 45 years and over (35 years for A&TSI peoples) who have no previous history of CVD. Correlation with the Guidelines for the Assessment of Absolute Cardiovascular Disease Risk ()
Sjöström L, Lindroos AK, Peltonen M. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. New Engl J Med. ; – Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk for ischaemic heart disease: a retrospective cohort study of births. Lancet. ; –:// Absolute cardiovascular disease risk is a person’s probability of developing cardiovascular disease in the next five years, based on a range of risk factors. Cardiovascular disease is largely preventable, with modifiable CVD risk factors accounting for up to 90% of the risk of myocardial ://
nutritional assessment and counseling for Patients with hyperlipidemia and other risk factors for cardiovascular disease should receive dietary counseling. B 3 Title:Disparities in Cardiovascular Disease Risk in the United States VOLUME: 11 ISSUE: 3 Author(s):Garth Graham Affiliation:University of Florida Department of Medicine, PO Box , Gainesville, FL USA. Keywords:Acute coronary, syndrome heart disease, health disparities, hypertension. Abstract:This is a comprehensive narrative review of the literature on the current
Rules and regulations for approval to perform mycobacteriologic examinations
design of land drainage works
Toward a political economy of the service society
The Jewish calendar explained, or, Observations on the ancient Hebrew account of the year, months, and festivals used by the patriarchs and mentioned in Holy Scripture
Forest habitat types of central Idaho
The spirit of modern philosophy
The Body Politic
Bert Wilson at the wheel
Reminiscences of a K.C.
Providing for the conveyance of interests of the United States in and to uranium, thorium, and other materials in certain tracts of land situated in Jackson County, Miss.
Report on the European non-thoroughbred horse breeding indutry
The last day, the last hour
Prognosis and Risk Assessment in Cardiovascular Disease. Amar S. Kapoor and Bramah N. Singh; eds. pages. New York: Churchill Livingstone; $ What makes a great clinician. No one sees enough cases to be ://?articleid= ISBN: OCLC Number: Description: xviii, pages: illustrations ; 26 cm: Contents: 38 Chapters in Seven Sections (Section Headings): SECTION I RISK FACTORS and PROGNOSIS SECTION II RISK ASSESSMENT and PROGNOSIS of CORONARY HEART DISEASE SECTION III RISK ASSESSMENT and PROGNOSIS of VALVULAR HEART DISEASE The use of risk markers has transformed cardiovascular medicine, exemplified by the routine assessment of troponin, for both diagnosis and assessment of prognosis in patients with chest pain.
Clinical risk factors form the basis for risk assessment of cardiovascular disease and the addition of biochemical, cellular, and imaging parameters Prognosis and risk assessment in cardiovascular disease edited by Amar S. Kapoor, Bramah N. Singh Churchill Livingstone, Abstract. Cardiovascular disease risk assessment and prediction rely on the measurement of a basic lipid panel.
This panel, represented by total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides, is routinely used in clinical :// Gaziano TA, Young CR, Fitzmaurice G, et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-Up Study cohort.
Lancet. ; ()– [PMC free article: PMC] [PubMed: ] Absolute CVD risk assessment combines risk factors to calculate the probability that an individual will develop a cardiovascular event (eg myocardial infarction, stroke) or other vascular disease within a specified time frame (usually five years).
/assessment-of-absolute-cardiovascular-risk. Risk stratification for primary prevention of cardiovascular disease is today performed using traditional risk factors such as age, gender, blood pressure, serum cholesterol, smoking habits, and plasma glucose.
However, these factors perform poorly in the daily clinic where individual risk prediction is :// Cardiovascular disease affects the heart and blood vessels. There are many types, including coronary artery disease, angina, and heart failure.
Following a heart-healthy diet and regularly The impact of cardiovascular disease in the prognosis of patients with rheumatoid arthritis (RA) RA, a chronic inflammatory disease that affects approximately 1% of the general population, is associated with increased mortality and reduced life expectancy, with standardized mortality rates ranging from to 1 – 6, e remarkable improvements in RA treatment, there is evidence Including risk assessment and prognosis for major cardiovascular entities in a single textbook is a highly attractive concept, and the editors are to be lauded for attempting this.
In some aspects, they succeed impressively; in others, they fall :// Risk Stratification and Prognosis. Conclusions: VTA occurred in % of pregnant women with cardiovascular disease, mainly in the third trimester, and was associated with heart failure during COVID and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia (atrial fibrillation, ventricular tachyarrhythmia, and ventricular fibrillation), cardiac injury Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta‐Analysis of Prospective Studies Up to Article Full /_Inflammation_Frailty_and_Cardiovascular_Disease.
Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis The following is a digest of ACC's clinical guidance on the cardiac implications of Coronavirus Disease (COVID).
Organized in an FAQ format for easy navigation, this guidance is summarized from more extensive documents approved by the ACC Science and Quality Committee and published on the ACC COVID Hub or in the Journal of the American College of :// The prognosis and burden of CVD have been discussed in other sections.
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive This book is distributed Cardiovascular disease risk assessment for primary prevention in adults: Our approach; Cardiovascular disease risk assessment for primary prevention: Risk calculators; lipid lowering) might improve the prognosis of those at high risk.
Other rationales for screening include certain high-risk occupations (eg, pilots, bus drivers) where an Afilalo J, Alexander KP, Mack MJ et al () Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol – CrossRef Google Scholar Atkins JL, Delgado J, Pilling LC, Bowman K, Masoli JAH, Kuchel GA et al () Impact of low cardiovascular risk profiles on geriatric outcomes: evidence fromparticipants in Within the population with stable coronary artery disease, an individual's prognosis can vary considerably, depending on baseline clinical, functional, and anatomical characteristics.
Prognostic assessment is an important part of the management of patients with stable ://. Blood Pressure Variability, Cardiovascular Risk, and Risk for Renal Disease Progression Article Literature Review (PDF Available) in Current Hypertension Reports 14(5) August Despite advances in cardiovascular disease (CVD) risk assessment and prevention, CVD remains a leading cause of morbidity and mortality.
Novel biomarkers may help to improve risk assessment for both atherosclerotic CVD and heart failure and to guide preventive :// COVID and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. May 8, We provide a comprehensive review of the clinical course of COVID, its comorbidities, and mechanistic considerations for future ://